| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IL15RA | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | LYSMD1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | APP | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | WDR54 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | CKLF-CMTM1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | C6orf52 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | FRZB | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GTF3C2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | LRRC41 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | THOC7 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
